CompaniesAntibody Analytics

Antibody Analytics

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

0

As Collaborator

4

Total Enrollment

2,093

By Phase

NA: 3

By Status

COMPLETED: 2NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT04605276
NCT06281769
NCT06935487
NCT06974539
Hover over trial bars to see details

Recent Trials

NCT06974539Collaborator
TULIP ReTrain Study
NANot yet recruiting
212 participants
Started: Jul 31, 2025 · Completed: Dec 31, 2026
NCT06935487Collaborator
European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametric Transrectal Ultrasound to MRI for Clinically Significant Prostate Cancer Detection
NAActive, not recruiting
806 participants
Started: Apr 1, 2025 · Completed: May 31, 2027
NCT06281769Collaborator
Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision
NACompleted
467 participants
Started: Feb 26, 2024 · Completed: Aug 15, 2025
NCT04605276Collaborator
Threedimensional Multiparametric Ultrasound for Prostate Cancer Detection
N/ACompleted
608 participants
Started: Jun 28, 2021 · Completed: Mar 7, 2024
Antibody Analytics | Biotech Hunter | Biotech Hunter